Bruce F Bell

Array ( [id] => 6805479 [patent_doc_number] => 20030232873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)' [patent_app_type] => new [patent_app_number] => 10/319833 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30101 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232873.pdf [firstpage_image] =>[orig_patent_app_number] => 10319833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721337 [patent_doc_number] => 20060074113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Thiadiazoline derivative' [patent_app_type] => utility [patent_app_number] => 10/497531 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40961 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074113.pdf [firstpage_image] =>[orig_patent_app_number] => 10497531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193246 [patent_doc_number] => 06730693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-04 [patent_title] => 'Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same' [patent_app_type] => B2 [patent_app_number] => 10/297843 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2631 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730693.pdf [firstpage_image] =>[orig_patent_app_number] => 10297843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209852 [patent_doc_number] => 06713499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => '7-Amino-benzothiazole derivatives' [patent_app_type] => B2 [patent_app_number] => 10/307702 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13594 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713499.pdf [firstpage_image] =>[orig_patent_app_number] => 10307702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026977 [patent_doc_number] => 20050020652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Peroxisome proliferator activated receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/496770 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85002 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020652.pdf [firstpage_image] =>[orig_patent_app_number] => 10496770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825781 [patent_doc_number] => 20030236403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Certain substituted 1-aryl-3-piperazine-1\'-yl propanones' [patent_app_type] => new [patent_app_number] => 10/304468 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22094 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236403.pdf [firstpage_image] =>[orig_patent_app_number] => 10304468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707020 [patent_doc_number] => 20030153754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands' [patent_app_type] => new [patent_app_number] => 10/303096 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14730 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153754.pdf [firstpage_image] =>[orig_patent_app_number] => 10303096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1282079 [patent_doc_number] => 06642263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Modulators of Rho C activity' [patent_app_type] => B2 [patent_app_number] => 10/300669 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6049 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642263.pdf [firstpage_image] =>[orig_patent_app_number] => 10300669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651420 [patent_doc_number] => 20030105064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2alpha antagonists' [patent_app_type] => new [patent_app_number] => 10/300492 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6276 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105064.pdf [firstpage_image] =>[orig_patent_app_number] => 10300492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402156 [patent_doc_number] => 20040019092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Non-peptide somatostatin receptor ligands' [patent_app_type] => new [patent_app_number] => 10/295079 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13128 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019092.pdf [firstpage_image] =>[orig_patent_app_number] => 10295079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369425 [patent_doc_number] => 20040006237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Amorphous and crystalline forms of losartan potassium and process for their preparation' [patent_app_type] => new [patent_app_number] => 10/293820 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9719 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006237.pdf [firstpage_image] =>[orig_patent_app_number] => 10293820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825630 [patent_doc_number] => 20030236252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Bicyclic cyclohexylamines and their use as nmda receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/276054 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38873 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236252.pdf [firstpage_image] =>[orig_patent_app_number] => 10276054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856828 [patent_doc_number] => 20030130329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension' [patent_app_type] => new [patent_app_number] => 10/290944 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7261 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130329.pdf [firstpage_image] =>[orig_patent_app_number] => 10290944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830421 [patent_doc_number] => 20030181479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Substituted imidazoles' [patent_app_type] => new [patent_app_number] => 10/290615 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17228 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181479.pdf [firstpage_image] =>[orig_patent_app_number] => 10290615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660242 [patent_doc_number] => 20030134886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Pharmaceutically active compounds' [patent_app_type] => new [patent_app_number] => 10/288329 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12656 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134886.pdf [firstpage_image] =>[orig_patent_app_number] => 10288329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093226 [patent_doc_number] => 06825219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Substituted benzimidazole compounds' [patent_app_type] => B2 [patent_app_number] => 10/288362 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8237 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825219.pdf [firstpage_image] =>[orig_patent_app_number] => 10288362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1181612 [patent_doc_number] => 06737432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-18 [patent_title] => 'Crystalline form of telmisartan sodium' [patent_app_type] => B2 [patent_app_number] => 10/283440 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4501 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737432.pdf [firstpage_image] =>[orig_patent_app_number] => 10283440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002483 [patent_doc_number] => 06908938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Heterocyclic aromatic compounds useful as growth hormone secretagogues' [patent_app_type] => utility [patent_app_number] => 10/281649 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21836 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908938.pdf [firstpage_image] =>[orig_patent_app_number] => 10281649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276467 [patent_doc_number] => 20040235918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Process for producing 2-cyanoimino-1,3-thiazolidine' [patent_app_type] => new [patent_app_number] => 10/470087 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3006 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235918.pdf [firstpage_image] =>[orig_patent_app_number] => 10470087 [rel_patent_id] =>[rel_patent_doc_number] =>)